CVS Health (CVS) Scheduled to Post Earnings on Wednesday

Share on StockTwits

CVS Health (NYSE:CVS) will announce its earnings results before the market opens on Wednesday, August 7th. Analysts expect the company to announce earnings of $1.70 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

NYSE:CVS opened at $54.51 on Tuesday. The stock’s 50 day simple moving average is $55.43. The company has a current ratio of 0.95, a quick ratio of 0.64 and a debt-to-equity ratio of 1.45. CVS Health has a one year low of $51.72 and a one year high of $82.15. The firm has a market cap of $72.37 billion, a P/E ratio of 7.70, a PEG ratio of 1.25 and a beta of 0.90.

The firm also recently announced a quarterly dividend, which was paid on Friday, August 2nd. Investors of record on Thursday, July 25th were given a dividend of $0.50 per share. The ex-dividend date was Wednesday, July 24th. This represents a $2.00 annualized dividend and a yield of 3.67%. CVS Health’s dividend payout ratio is presently 28.25%.

Several equities research analysts recently commented on CVS shares. Credit Suisse Group downgraded shares of CVS Health from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $73.00 to $61.00 in a research report on Monday, April 29th. Cantor Fitzgerald restated a “buy” rating and issued a $80.00 price target on shares of CVS Health in a research report on Wednesday, May 1st. Barclays set a $73.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research report on Thursday, April 11th. Bank of America restated a “buy” rating and issued a $74.00 price target (down previously from $82.00) on shares of CVS Health in a research report on Wednesday, April 10th. Finally, Oppenheimer downgraded shares of CVS Health from an “outperform” rating to a “market perform” rating in a research report on Monday, April 15th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the stock. CVS Health presently has an average rating of “Buy” and an average target price of $76.48.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. Its Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, Medicare Part D, clinical, disease management, and medical spend management services.

Further Reading: How to calculate the intrinsic value of a stock

Earnings History for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Cloverdale Capital Management LLC Buys 18,772 Shares of Mohawk Industries, Inc.
Cloverdale Capital Management LLC Buys 18,772 Shares of Mohawk Industries, Inc.
Perspecta Inc  Shares Sold by Cloverdale Capital Management LLC
Perspecta Inc Shares Sold by Cloverdale Capital Management LLC
Eminence Capital LP Invests $12.90 Million in Sothebys
Eminence Capital LP Invests $12.90 Million in Sothebys
Eminence Capital LP Has $26.53 Million Stake in Asbury Automotive Group, Inc.
Eminence Capital LP Has $26.53 Million Stake in Asbury Automotive Group, Inc.
Eminence Capital LP Cuts Holdings in TAKE-TWO INTERACTIVE SOFTWARE, INC
Eminence Capital LP Cuts Holdings in TAKE-TWO INTERACTIVE SOFTWARE, INC
Eminence Capital LP Sells 226,265 Shares of Thermo Fisher Scientific Inc.
Eminence Capital LP Sells 226,265 Shares of Thermo Fisher Scientific Inc.


© 2006-2019 Ticker Report